Booster Immunization Improves Memory B Cell Responses in Older Adults Unresponsive to Primary SARS-CoV-2 Immunization

被引:7
|
作者
Verheul, Marije K. [1 ]
Nijhof, Kim H. [1 ]
de Zeeuw-Brouwer, Mary-lene [1 ]
Duijm, Geraly [1 ]
ten Hulscher, Hinke [1 ]
de Rond, Lia [1 ]
Beckers, Lisa [1 ]
Eggink, Dirk [2 ]
Van Tol, Sophie [2 ]
Reimerink, Johan [2 ]
Boer, Mardi [1 ]
Van Beek, Josine [1 ]
Rots, Nynke [1 ]
Van Binnendijk, Rob [1 ]
Buisman, Anne-Marie [1 ]
机构
[1] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Ctr Immunol Infect Dis & Vaccines, NL-3721 MA Bilthoven, Netherlands
[2] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Ctr Infect Dis Res Diagnost & Lab Surveillance, WHO COVID 19 Reference Lab, NL-3721 MA Bilthoven, Netherlands
关键词
memory B cells; SARS-CoV-2; older adults; coronavirus; booster; primary vaccination; antibodies; COHORT PROFILE; IMMUNOGENICITY; INFECTION; VACCINES; NUMBERS; AGE;
D O I
10.3390/vaccines11071196
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The generation of a specific long-term immune response to SARS-CoV-2 is considered important for protection against COVID-19 infection and disease. Memory B cells, responsible for the generation of antibody-producing plasmablasts upon a new antigen encounter, play an important role in this process. Therefore, the induction of memory B cell responses after primary and booster SARS-CoV-2 immunizations was investigated in the general population with an emphasis on older adults. Participants, 20-99 years of age, due to receive the mRNA-1273 or BNT162b2 SARS-CoV-2 vaccine were included in the current study. Specific memory B cells were determined by ex vivo ELISpot assays. In a subset of participants, antibody levels, avidity, and virus neutralization capacity were compared to memory B cell responses. Memory B cells specific for both Spike S1 and receptor-binding domain (RBD) were detected in the majority of participants following the primary immunization series. However, a proportion of predominantly older adults showed low frequencies of specific memory B cells. Booster vaccination resulted in a large increase in the frequencies of S1- and RBD-specific memory B cells also for those in which low memory B cell frequencies were detected after the primary series. These data show that booster immunization is important for the generation of a memory B cell response, as a subset of older adults shows a suboptimal response to the primary SARS-CoV-2 immunization series. It is anticipated that these memory B cells will play a significant role in the immune response following viral re-exposure.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] SARS-CoV-2 booster immunization: stimulating de novo B-cell response and antibody generation
    Hong, Qiaonan
    Bai, Ziyi
    Tian, Dong
    MEDCOMM, 2023, 4 (06):
  • [2] SARS-CoV-2 Vaccine and Booster Immunization Response in Patients with Humoral Immunodeficiency
    Barmettler, Sara
    DiGiacomo, Daniel
    Yang, Nancy
    Lam, Tiffany
    Naranbhai, Vivek
    Dighe, Anand
    Burke, Kristin
    Farmer, Jocelyn
    JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (SUPPL 1) : S98 - S99
  • [3] Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS-CoV-2 Variants after Primary and Booster Immunization
    Xie, Hui
    Wen, Xiaojing
    Li, Juan
    Chen, Weixin
    Chen, Meng
    Zhang, Lichi
    Lv, Min
    Zhou, Shanshan
    Bai, Shuang
    Zhao, Wei
    Wang, Jian
    Wu, Jiang
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 117 : 97 - 102
  • [4] Ipsilateral immunization after a prior SARS-CoV-2 mRNA vaccination elicits superior B cell responses compared to contralateral immunization
    Jiang, Wenxia
    Maldeney, Alexander R.
    Yuan, Xue
    Richer, Martin J.
    Renshaw, Scott E.
    Luo, Wei
    CELL REPORTS, 2024, 43 (01):
  • [5] Receptor-Binding-Domain-Specific B Cell Responses Induced by mRNA Immunization against SARS-CoV-2
    Geropeppa, Maria
    Papadatou, Ioanna
    Sarantis, Panagiotis
    Tzanoudaki, Marianna
    Ntanasis-Stathopoulos, Ioannis
    Bagratuni, Tina
    Terpos, Evangelos
    Spoulou, Vana
    VACCINES, 2023, 11 (07)
  • [6] An update on SARS-CoV-2 immunization and future directions
    Rana, Rashmi
    Kant, Ravi
    Kumra, Tanya
    Gupta, Sneha
    Rana, Devinder Singh
    Ganguly, Nirmal Kumar
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization
    Chandrasekar, Shaswath S.
    Phanse, Yashdeep
    Hildebrand, Rachel E.
    Hanafy, Mostafa
    Wu, Chia-Wei
    Hansen, Chungyi H.
    Osorio, Jorge E.
    Suresh, M.
    Talaat, Adel M.
    VACCINES, 2021, 9 (02) : 1 - 17
  • [8] Implementing digital passports for SARS-CoV-2 immunization in Canada
    Wilson, Kumanan
    Flood, Colleen M.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (14) : E486 - E488
  • [9] Immune Persistence against SARS-CoV-2 after Primary and Booster Immunization in Humans: A Large-Scale Prospective Cohort Study
    Li, Juan
    Xie, Hui
    Chen, Weixin
    Chen, Meng
    Bai, Shuang
    Zhao, Wei
    Zhou, Tao
    Gao, Pei
    Zhang, Lichi
    Wang, Quanyi
    Pang, Xinghuo
    Huang, Chun
    Wu, Jiang
    VACCINES, 2022, 10 (10)
  • [10] Eye Infection with SARS-CoV-2 as a Route to Systemic Immunization?
    Schrage, Norbert
    Blomet, Joel
    Holzer, Frank
    Tromme, A.
    Ectors, F.
    Desmecht, Daniel
    VIRUSES-BASEL, 2022, 14 (07):